CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $567,148 | +2.9% | 446,573 | +12.6% | 0.00% | – |
| Q1 2024 | $551,355 | -2.4% | 396,658 | +11.7% | 0.00% | – |
| Q4 2023 | $564,805 | +41.0% | 355,223 | +26.0% | 0.00% | – |
| Q3 2023 | $400,478 | -3.3% | 282,027 | +8.3% | 0.00% | – |
| Q2 2023 | $413,999 | +94.1% | 260,377 | +2.6% | 0.00% | – |
| Q1 2023 | $213,286 | -40.8% | 253,882 | 0.0% | 0.00% | – |
| Q4 2022 | $360,512 | -26.4% | 253,882 | +0.0% | 0.00% | – |
| Q3 2022 | $490,000 | -2.0% | 253,765 | 0.0% | 0.00% | – |
| Q2 2022 | $500,000 | -38.1% | 253,765 | -0.5% | 0.00% | – |
| Q1 2022 | $808,000 | -14.8% | 255,065 | +0.3% | 0.00% | – |
| Q4 2021 | $948,000 | -18.2% | 254,301 | +48.1% | 0.00% | – |
| Q3 2021 | $1,159,000 | -25.2% | 171,681 | +13.3% | 0.00% | – |
| Q2 2021 | $1,550,000 | +461.6% | 151,540 | +350.4% | 0.00% | – |
| Q1 2021 | $276,000 | – | 33,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 260,377 | $413,999 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,348 | $3,733 | 0.00% |
| NORTHERN TRUST CORP | 16,593 | $26,383 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| IFP Advisors, Inc | 26 | $76 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,600 | $7,314 | 0.00% |
| Princeton Global Asset Management LLC | 300 | $477 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 100,388 | $159,616 | 0.00% |
| BlackRock Inc. | 362 | $576 | 0.00% |
| Citadel Advisors | 16,979 | $26,997 | 0.00% |